Surgery Partners/$SGRY

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Surgery Partners

Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.

Ticker

$SGRY
Sector
Primary listing

Employees

15,000

Surgery Partners Metrics

BasicAdvanced
$2.9B
-
-$1.43
1.82
-

What the Analysts think about Surgery Partners

Analyst ratings (Buy, Hold, Sell) for Surgery Partners stock.

Bulls say / Bears say

Second-quarter revenue grew 8.4% year-on-year to $826.2 million, adjusted EBITDA rose 9% to $129.0 million, and the company beat analyst estimates while reaffirming full-year 2025 guidance
Bain Capital’s non-binding proposal to acquire remaining shares at $25.75 per share represented a 21.2% premium and sent SGRY shares up about 17%, underscoring strong intrinsic value
Wall Street consensus remains a “buy” with a median 12-month price target of $33.00, implying roughly 33% upside from recent levels
High leverage with a net debt to EBITDA ratio of approximately 4.1x at the end of Q1 2025, above industry averages and potentially limiting financial flexibility
Operating cash flow plunged to $6.0 million in Q1 2025 from $40.7 million a year earlier, indicating working capital pressures and higher interest costs
Bain Capital’s 21.2% acquisition premium may invite competing higher bids and extend strategic uncertainty for shareholders
Data summarised monthly by Lightyear AI. Last updated on 2 Sept 2025.

Surgery Partners Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Surgery Partners Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SGRY

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs